Xeris Biopharma Holdings, Inc. (2B30)
Market Closed
17 Jul, 20:00
XFRA 
€
7. 46
+0
+0.0537%
€
- Market Cap
- P/E Ratio
- Div Yield
2,100 Volume
-0.38 Eps
€ 7.45
Previous Close Want to track 2B30 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 0.05 | - |
| | | 0.02 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
2B30 Earnings Reports FAQ
What is the earnings per share (EPS) for 2B30?
The current EPS is -0.38.
What is the company's earnings growth rate?
Xeris Biopharma Holdings, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Xeris Biopharma Holdings, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Xeris Biopharma Holdings, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 2B30 at this time, as Xeris Biopharma Holdings, Inc has no recent EPS data to calculate it.
